SAFLUTAN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Spain, Croatia, Ireland, Israel, Malta, Mexico, Netherlands, Romania, Tunisia, United Kingdom, South Africa

Active ingredients

The drug SAFLUTAN contains one active pharmaceutical ingredient (API):

1 Tafluprost UNII 1O6WQ6T7G3 - TAFLUPROST

Tafluprost is a fluorinated analogue of prostaglandin F2α. Tafluprost acid, the biologically active metabolite of tafluprost, is a highly potent and selective agonist of the human prostanoid FP receptor. Read about Tafluprost

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SAFLUTAN Eye drops, solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EE05	Tafluprost	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2748P, 2755B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 556717110001517, 556717110001607
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70063
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 158690, 373807, 377205
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-485560365, HR-H-499250915
Country: IE	Health Products Regulatory Authority	Identifier(s): 31005, 36899
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7010
Country: MT	Medicines Authority	Identifier(s): AA1068/00202, MA1068/00201
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 241M2014
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 167614, 93408
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62677001, W62677002, W65332001, W65332002, W65332003, W65332004
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 18583021
Country: ZA	Health Products Regulatory Authority	Identifier(s): 45/15.4/0710